Jubilant Pharmova Limited
Stock Forecast, Prediction & Price Target

Jubilant Pharmova Limited Financial Estimates

Jubilant Pharmova Limited Revenue Estimates

Jubilant Pharmova Limited EBITDA Estimates

Jubilant Pharmova Limited Earnings per Share Estimates

Passed Analyst forecast
Metric 3/31/2021 3/31/2022 3/31/2024 3/31/2026
Revenue
 
% change YoY
₹59.63B
 
N/A
₹60.59B
 
1.59%
₹66.44B
 
9.66%
Avg: ₹78.81B
Low: ₹78.81B
High: ₹78.81B
avg. 18.60%
Net Income
 
% change YoY
₹8.35B
 
N/A
₹4.13B
 
-50.47%
₹771M
 
-81.37%
Avg: ₹5.11B
Low: ₹5.11B
High: ₹5.11B
avg. 563.15%
EBITDA
 
% change YoY
₹13.92B
 
N/A
₹11.53B
 
-17.17%
₹8.08B
 
-29.88%
Avg: ₹14.71B
Low: ₹14.71B
High: ₹14.71B
avg. 81.95%
EPS
 
% change YoY
$52.48
 
N/A
$26.01
 
-50.43%
$4.86
 
-81.31%
Avg: $32.1
Low: $32.1
High: $32.1
avg. 560.49%
Operating Expenses
 
% change YoY
₹30.91B
 
N/A
₹34.47B
 
11.51%
₹14.45B
 
-58.07%
Avg: ₹7.24B
Low: ₹7.24B
High: ₹7.24B
avg. -49.88%

FAQ

What is Jubilant Pharmova Limited stock earnings growth forecast?

Wall Street analysts estimate the annual average earnings growth rate of 563.15% in 2026-2026.

We have gathered data from N/A analysts. Their low estimate is 5.11B, average is 5.11B and high is 5.11B.

What is Jubilant Pharmova Limited stock revenue growth forecast?

Wall Street analysts forecast annual average revenue growth of 18.60% in 2026-2026.

We have gathered data from N/A analysts. Their low revenue estimate is ₹78.81B, average is ₹78.81B and high is ₹78.81B.

What is Jubilant Pharmova Limited stock earnings per share growth forecast?

Wall Street analysts forecast annual average earnings growth of 560.49% in 2026-2026.

We have gathered data from N/A analysts. Their low earnings per share estimate is $32.1, average is $32.1 and high is ₹32.1.